Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 24, 2026
FIGS Stock Jumps +48% in 30 Days After Strong Earnings Beat

FIGS Stock Jumps +48% in 30 Days After Strong Earnings Beat

Key Takeaways

  • FIGS shares climbed roughly 48% over the last 30 days, rising from about $9.92 in late July to $14.68 at the most recent close.
  • The surge was driven by a second-quarter earnings beat that came in well above Wall Street expectations, plus a raised full-year outlook.
  • Revenue grew 28.8% year over year to $196.6 million, while GAAP earnings per share of $0.15 more than doubled the $0.07 consensus estimate.
  • Management lifted fiscal 2026 revenue growth guidance to roughly 20%, up from a prior range of 14% to 16%, and added a new $100 million buyback authorization.
  • Valuation has expanded sharply, leaving shares trading at a premium that raises the bar for continued execution.

Understanding FIGS, Inc. (FIGS) and Its Market Position

FIGS, Inc. is a direct-to-consumer designer and retailer of medical apparel and accessories for healthcare professionals. Founded in 2013 by Heather Hasson and Trina Spear, the company disrupted the traditional scrub uniform market by pairing technical, functional fabrics with a premium, fashion-forward brand identity. Its product line spans scrub sets, lab coats, underscrubs, outerwear, footwear, compression socks, and accessories built around proprietary performance fabrics.

The company sells primarily through its e-commerce platform and mobile app, complemented by a growing network of physical "Community Hubs" and a "Teams" institutional channel that outfits healthcare organizations. FIGS differentiates itself through brand storytelling, limited-edition collaborations, and a focus on fit and comfort, which has supported strong customer loyalty and higher-than-average order values. Investors follow the stock closely because of its exposure to non-discretionary, replenishment-driven healthcare apparel demand and its international expansion runway. When I reviewed comparable names in the sector, I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

FIGS Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, FIGS shares climbed approximately 48%, advancing from around $9.92 in late July to $14.68 at the most recent close. The move was concentrated in a single session in early August, when the stock jumped more than 25% after second-quarter results were released, before consolidating in the mid-$14 range. From what I see, that kind of sharp reaction often signals a meaningful shift in sentiment.

The trailing three-month picture reflects a more volatile path. Shares entered the period near $12, declined through June and July to a low around $9.17, and then recovered sharply on the earnings-driven rebound. Net of that volatility, the stock finished the quarter up roughly 20%, but it remains below its 52-week high. I’m watching this closely because the rebound has now pushed valuation metrics into new territory.

What Drove the Recent Surge in FIGS Shares

The dominant catalyst was the company's second-quarter earnings report. FIGS posted net revenue of $196.6 million, up 28.8% year over year and ahead of analyst estimates, while GAAP earnings per share of $0.15 far exceeded the $0.07 consensus. Net income rose to $28.4 million from $7.1 million a year earlier.

Growth was broad-based: scrubwear revenue rose 27%, non-scrubwear grew 40%, U.S. revenue increased 22%, and international revenue jumped 67%. Active customers grew 13% to 3.1 million, average order value reached a record $127, and net revenue per active customer hit an all-time high of $229.

Profitability also improved sharply. Gross margin expanded 820 basis points to 75.2%, including a benefit from a $15.4 million IEEPA tariff refund, and adjusted EBITDA margin rose to 18.6% from 12.9% a year earlier. Management raised its full-year 2026 revenue growth outlook to approximately 20% and authorized an additional $100 million in share repurchases. Several analysts lifted their price targets following the report, reinforcing positive sentiment.

Looking Back at the Quarter’s Mixed Performance

The quarterly trend was shaped by two opposing forces. Earlier in the period, shares fell roughly 26% after the company's first-quarter report, which beat headline expectations but disappointed investors on free cash flow and active customer growth. That weakness carried the stock to a multi-month low near $9.17 in late July.

The narrative reversed with the second-quarter report, which demonstrated accelerating profitability, record customer economics, and raised guidance. The acquisition of V Coterie, a maker of healthcare-focused jewelry and accessories, signaled a push into adjacent categories, while international and institutional channels provided incremental growth drivers. A U.S. Customs and Border Protection order affecting imports from a Jordan manufacturing partner introduced a near-term supply-chain overhang, but management indicated it had already shifted capacity and air freight to mitigate the impact.

FIGS Stock Forecast Drivers: What to Watch Next

Looking ahead, investors will monitor several factors. Execution against the raised guidance will be a key test, particularly in the fourth quarter, which faces a difficult comparison against roughly 33% growth a year earlier. The Jordan import restriction and the use of expedited freight represent margin risks in the second half, while the timing and sell-through of tariff-related inventory benefits will affect reported profitability.

Continued progress in international expansion, the Teams institutional channel, and Community Hub store openings will indicate whether growth can broaden further. Demand trends such as active customer growth, average order value, and purchase frequency remain central to the story. Finally, valuation is a key consideration: with shares trading at a substantial premium to industry peers on a forward earnings basis, the market will require sustained growth and margin delivery to justify current levels. One thing that stands out here is how quickly expectations have reset higher.

Exploring Tickeron’s Trending AI Robots for Additional Context

For traders seeking a data-driven edge, I’ve found Tickeron’s Trending AI Robots page helpful when reviewing momentum in names like this. It highlights a curated selection of top-performing AI trading bots across different strategies and timeframes, allowing users to compare approaches and identify signals that align with their own style. In my analysis, it offers one more lens on how automated strategies are currently positioned around healthcare apparel names.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FIGS

FIGS in upward trend: 10-day moving average crossed above 50-day moving average on August 07, 2026

The 10-day moving average for FIGS crossed bullishly above the 50-day moving average on August 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on FIGS as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FIGS moved above its 50-day moving average on August 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FIGS advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where FIGS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FIGS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FIGS broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FIGS entered a downward trend on August 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FIGS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.513) is normal, around the industry mean (6.314). P/E Ratio (44.485) is within average values for comparable stocks, (29.463). FIGS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.954). FIGS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.024). FIGS's P/S Ratio (3.939) is very high in comparison to the industry average of (0.912).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FIGS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are VF Corp (NYSE:VFC), G-III Apparel Group Ltd (NASDAQ:GIII), Canada Goose Holdings (NYSE:GOOS), Lakeland Industries (NASDAQ:LAKE).

Industry description

Apparel/footwear might be slightly more ‘cyclical’ in the largely non-cyclical category of non-durables. While digital giants like Amazon have been rapidly expanding their presence, traditional clothing/footwear retailers have also been bulking up their online presence in recent years, to milk the burgeoning trend of online shopping among consumers across the globe. The apparel and footwear retail market was valued at around $ 360 billion in 2018, and this figure was expected to reach about $386 billion by 2020 (according to a Statista report). NIKE, Inc, V.F. Corporation and Under Armour, Inc. are some of the companies with the largest U.S. stock market caps in this segment.

Market Cap

The average market capitalization across the Apparel/Footwear Industry is 3.13B. The market cap for tickers in the group ranges from 1.66K to 27.62B. HNNMY holds the highest valuation in this group at 27.62B. The lowest valued company is SQBGQ at 1.66K.

High and low price notable news

The average weekly price growth across all stocks in the Apparel/Footwear Industry was -0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 4%. NCI experienced the highest price growth at 6%, while XELB experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Apparel/Footwear Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 52
Price Growth Rating: 57
SMR Rating: 70
Profit Risk Rating: 91
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
FIGS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ApparelFootwear

Profile
Details
Industry
N/A
Address
2834 Colorado Avenue
Phone
+1 424 300-8330
Employees
354
Web
https://www.wearfigs.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.